Refeeding Syndrome: Feeding Cautiously After Starvation
Key points
- Refeeding syndrome: the potentially fatal shift in fluid and electrolytes that occurs when carbohydrate is reintroduced after a period of prolonged starvation or catabolism.
- Mechanism: starvation depletes total-body phosphate, potassium and magnesium despite normal serum levels; feeding triggers an insulin surge that drives glucose and these electrolytes rapidly into cells, causing severe extracellular deficiency.
- Hallmark abnormality: hypophosphataemia, but hypokalaemia and hypomagnesaemia occur alongside it and each carries its own risks.
- At-risk groups: very low BMI, marked recent weight loss, prolonged minimal intake, alcohol misuse, and use of insulin, chemotherapy, antacids or diuretics. NICE defines specific high-risk and very-high-risk criteria.
- Major consequences: cardiac arrhythmia and failure, respiratory failure from diaphragmatic weakness, rhabdomyolysis, seizures, and Wernicke's encephalopathy if thiamine is not replaced before carbohydrate is given.
- Prevention is everything: identify at-risk patients before feeding starts, feed cautiously at a low calorie level with slow build-up, give prophylactic thiamine and vitamin B co-strong before feeding begins, and correct electrolytes proactively.
- Monitoring: daily electrolytes (phosphate, potassium, magnesium), fluid balance and cardiac status through the highest-risk period, typically the first week of feeding.
Introduction
Refeeding syndrome is the group of potentially life-threatening fluid and electrolyte shifts that can occur when nutrition (particularly carbohydrate) is reintroduced too quickly after a period of prolonged starvation, malnutrition or significant catabolic stress. It is entirely preventable with anticipation and a cautious feeding regimen, which is why identifying at-risk patients before feeding starts is the single most important step in managing it.
It can occur with oral, enteral or parenteral feeding, and is seen across a wide range of settings - eating disorders, prolonged fasting or vomiting, alcohol use disorder, chronic illness with poor intake, post-operative patients, and older adults admitted after a prolonged period of poor oral intake at home.
Pathophysiology
Understanding the mechanism explains every subsequent management decision.
- During prolonged starvation, the body shifts from carbohydrate to fat and protein metabolism to preserve glucose for the brain and red cells. Insulin secretion falls and glucagon rises.
- Intracellular phosphate, potassium and magnesium become progressively depleted as cells break down and total body stores fall, but crucially serum levels are often maintained within the normal range, because these ions shift out of dying and catabolised cells to compensate, and renal excretion falls. The deficit is therefore easily missed on a routine blood test taken before feeding.
- Reintroducing carbohydrate - even a modest amount - stimulates a surge in insulin secretion. Insulin drives glucose into cells for glycolysis and glycogen synthesis, and phosphate, potassium and magnesium are co-transported into cells alongside it, along with increased cellular uptake for the synthesis of ATP and other phosphorylated intermediates.
- Because total body stores of these ions are already depleted, this intracellular shift produces a severe fall in their serum (extracellular) concentration - hypophosphataemia, hypokalaemia and hypomagnesaemia - which is the syndrome itself.
- Insulin also promotes renal sodium and water retention, and the sudden nutritional and fluid load can precipitate fluid overload and cardiac failure, particularly in a heart that has itself undergone catabolic atrophy during starvation.
- Thiamine (vitamin B1) is a co-factor for carbohydrate metabolism (used up in glycolysis and the citric acid cycle) and body stores are often already low after prolonged poor intake or alcohol excess; providing a carbohydrate load without first replacing thiamine can precipitate acute deficiency and Wernicke's encephalopathy.
At-risk groups and NICE criteria
NICE (in guideline CG32, nutrition support in adults) sets out specific criteria to identify patients at high risk and at very high risk of refeeding problems, and these should be checked in anyone starting nutritional support after a period of reduced intake.1
| Category | Criteria |
|---|---|
| Major criteria (any one) | BMI below 16 kg/m2; unintentional weight loss of more than 15% within the last 3-6 months; little or no nutritional intake for more than 10 days; low potassium, phosphate or magnesium before feeding |
| Minor criteria (two or more) | BMI below 18.5 kg/m2; unintentional weight loss of more than 10% within the last 3-6 months; little or no nutritional intake for more than 5 days; a history of alcohol misuse, or drugs including insulin, chemotherapy, antacids or diuretics |
| Criterion |
|---|
| BMI below 14 kg/m2 |
| Negligible intake for more than 15 days |
| Existing significantly low levels of potassium, phosphate or magnesium requiring correction before feeding starts |
Other groups worth considering even outside the formal criteria include patients with anorexia nervosa or other eating disorders, chronic alcohol use disorder, prolonged post-operative ileus or bowel obstruction, malignancy with cachexia, uncontrolled diabetes, and older or frail patients admitted after prolonged poor oral intake at home.
Clinical consequences
The clinical picture reflects the combined effects of hypophosphataemia, hypokalaemia, hypomagnesaemia and fluid overload, and can evolve rapidly once feeding starts.
| Abnormality | Consequences |
|---|---|
| Hypophosphataemia (the hallmark abnormality) | Muscle weakness and rhabdomyolysis; respiratory failure from diaphragmatic weakness (may require ventilatory support); cardiac dysfunction and arrhythmia, including acute heart failure; red cell dysfunction from reduced 2,3-DPG, impairing oxygen delivery; also confusion, seizures and reduced consciousness in severe cases |
| Hypokalaemia | Cardiac arrhythmia (including life-threatening ventricular arrhythmia), muscle weakness, and paralytic ileus |
| Hypomagnesaemia | Cardiac arrhythmia, tremor, seizures, and it also worsens and perpetuates both hypokalaemia and hypocalcaemia if left uncorrected, since magnesium is required for normal potassium and calcium homeostasis |
| Sodium and fluid retention | Fluid overload, peripheral oedema and acute cardiac failure, particularly in a heart weakened by prior starvation |
| Thiamine deficiency | Wernicke's encephalopathy - the classic triad of confusion, ataxia and ophthalmoplegia - if carbohydrate is given before thiamine is replaced; risk of progression to irreversible Korsakoff syndrome if untreated |
Management and prevention
Refeeding syndrome is managed principally through prevention - identifying risk before feeding starts and feeding cautiously - rather than through treatment after the event.
Before feeding starts
- Identify at-risk patients using the NICE high-risk and very-high-risk criteria above, in every patient starting nutritional support
- Check baseline U&Es, phosphate, magnesium and calcium, and correct any pre-existing deficiency where possible before or alongside starting feeding, rather than waiting for it to normalise first in very high-risk patients
- Give prophylactic thiamine and vitamin B co-strong (plus a multivitamin/trace element supplement) before feeding starts and continued through the first days of feeding, to prevent precipitating Wernicke's encephalopathy
- Involve a dietitian early to plan the feeding regimen and rate of increase
Starting feeding
- Start at a low calorie intake and build up slowly, rather than immediately targeting full nutritional requirements. NICE suggests starting at around 10 kcal/kg/day in high-risk patients (as low as 5 kcal/kg/day in the most extreme, very high-risk cases), increasing gradually over 4-7 days towards full requirements if clinically and biochemically stable
- In patients at lower risk within the 'at-risk' category, a less restrictive starting point (e.g. around 20 kcal/kg/day) may be used, guided by dietitian input and local protocol
- Restrict sodium and fluid where there is a risk of fluid overload, and monitor fluid balance and weight closely
- Continue for the whole high-risk period, typically the first 7-10 days of feeding, before advancing to standard nutritional targets
During feeding
- Check and aggressively replace potassium, phosphate and magnesium before feeding and daily during the high-risk period, correcting proactively rather than waiting for levels to fall further
- Monitor electrolytes, fluid balance and clinical/cardiac status daily for at least the first week, more frequently in the very highest-risk patients or if abnormalities are found
- Continuous cardiac monitoring where there is significant electrolyte derangement or very high risk
- Do not stop feeding altogether if abnormalities are found - correct the electrolytes while continuing (or briefly slowing) feeding, under dietitian and senior guidance, since prolonging starvation carries its own risk
Red flags
Prognosis
With a proactive, protocol-driven approach - risk stratification before feeding, cautious calorie escalation, prophylactic thiamine and daily electrolyte monitoring - refeeding syndrome is largely preventable, and most at-risk patients are fed successfully without significant complication. Where it does occur and is recognised promptly, most biochemical and clinical abnormalities respond well to electrolyte correction and adjustment of the feeding rate. Delayed recognition, however, carries a real risk of fatal arrhythmia, respiratory failure or irreversible neurological injury, which is why anticipation rather than treatment is the central principle of this topic.
References
- NICE CG32. Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition. 2006, updated 2017. Available here
- NICE Clinical Knowledge Summaries. Nutrition support in adults. Available here
- Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2008. Available here
- BNF. Thiamine and vitamin B compound preparations. Available here
This article is written for revision and education. It is not clinical guidance and must not be used to make decisions about the care of a patient. Always check current NICE guidance and local protocols.